Breaking News

Youth vaping rates appear to be dropping; citing Ebola outbreak, U.S. to screen travelers arriving from Uganda

     

 

Daily Recap

Youth vaping rates appear to be dropping, but regulators and advocates aren't satisfied

By Nicholas Florko

Marshall Ritzel/AP

A new survey from the CDC and the FDA suggests that youth vaping rates appear to be dropping, compared to pre-pandemic levels.

Read More

Citing Ebola outbreak in Uganda, U.S. to screen all passengers arriving from there

By Andrew Joseph

Hajarah Nalwadda/AP

Passengers will be sent to one of five airports for Ebola screening, reflecting global concerns about the new cases.

Read More

STAT+: Alzheimer's clinical trials have a recruitment problem. Telehealth platform Ro thinks it can help 

By Mario Aguilar

Evan Vucci/AP

Alzheimer’s clinical trials have a recruitment problem. Telehealth platform Ro just struck an agreement with the NIA to try to help.

Read More

The U.S. is terrible at keeping businesses from worsening public health, experts say

By Nicholas Florko

Hyacinth Empinado/STAT

STAT asked 10 experts to grade the U.S. approach to preventing business from driving sickness and death. No one gave higher than a C+.

Read More

Call it data liberation day: Patients can now access all their health records digitally  

By Casey Ross

Adobe

Under new federal rules, health care organizations must give patients unfettered access to their full health records in digital format.

Read More

From BQ.1.1 to XBB and beyond: How the splintering of Omicron variants could shape Covid's next phase

By Andrew Joseph

NIAID

A virologist discusses the bevy of new forms of Omicron that are jockeying with each other to become the next dominant strain.

Read More

STAT+: 'Patchy efforts' by major insulin makers mean access lags in many poor countries

By Ed Silverman

Alissa Ambrose/STAT

“The global inequity is so stark and... I think we need to do something about this,” said Jayasree Iyer of the Access to Medicines Foundation.

Read More

Listen: Nobels for science, biotech dealmaking, & a friendly FTC

By Damian Garde and Allison DeAngelis and Adam Feuerstein

STAT science writer Megan Molteni joins us to explain this year's Nobel-Prize-winning work in medicine and chemistry.

Read More

Thursday, October 6, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments